SCHEMBL23977681

SCHEMBL23977681

Clc1ccc2ncc(-c3nc(-c4ccc(Br)cc4)no3)n2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.47
NR1H4 Q96RI1 2/20 0.46
RAB9A P51151 5/20 0.45
NPC1 O15118 4/20 0.45
CASP3 P42574 6/20 0.44
PKM P14618 1/20 0.42
FLT3 P36888 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25812124 0.88 NR1H4 (0.57) NR1H4RAB9ANPC1CASP3FLT3
SCHEMBL23977683 0.82 SMN1; SMN2 (0.47) RAB9ANPC1SMN1; SMN2MEN1HPGD
SCHEMBL23977684 0.80 NR1H4 (0.38) NR1H4RAB9ANPC1CASP3PKM
SCHEMBL23977685 0.78 TSHR (0.55) NPC1SMN1; SMN2MEN1HPGDKMT2A
SCHEMBL312801 0.77 FLT3 (0.44) NR1H4RAB9ANPC1CASP3PKM
SCHEMBL25322090 0.76 PIK3CA (0.38) AHRNR1H4RAB9ANPC1FLT3
SCHEMBL15288131 0.74 FYN (0.55) AHRRAB9ANPC1FLT3SMN1; SMN2
SCHEMBL3849418 0.73 NR1H4 (0.52) NR1H4RAB9ANPC1PKMFLT3
SCHEMBL25813764 0.73 NPC1 (0.45) NR1H4RAB9ANPC1CASP3PKM
SCHEMBL12998313 0.73 PIK3CA (0.48) FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease US GOV VETERANS AFFAIRS (US) 2023-07-13 US disclosed
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease US GOV VETERANS AFFAIRS (US) 2023-07-13 US disclosed
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-05-09 US disclosed
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-05-09 US disclosed
WO-2021222637-A1 KRÜPPEL-LIKE FACTOR 15 (KLF15) SMALL MOLECULE AGONISTS IN KIDNEY DISEASE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease KIF15, KLF5, KLF10 AHR 1053/4885NR1H4 1765/4885RAB9A 1697/4885
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease KIF15, KLF5, KLF10 AHR 1053/4885NR1H4 1765/4885RAB9A 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.